Cargando…
A bipartite graph-based expected networks approach identifies DDR genes not associated with TMB yet predictive of immune checkpoint blockade response
Immune checkpoint blockade (ICB) has had remarkable success for treatment of solid tumors. However, as only a subset of patients exhibit responses, there is a continued need for biomarker development. Numerous reports have shown a link between tumor mutational burden (TMB) and ICB response, while ot...
Autores principales: | Weir, William H., Mucha, Peter J., Kim, William Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133403/ https://www.ncbi.nlm.nih.gov/pubmed/35584624 http://dx.doi.org/10.1016/j.xcrm.2022.100602 |
Ejemplares similares
-
Biological Pathway-Derived TMB Robustly Predicts the Outcome of Immune Checkpoint Blockade Therapy
por: Miao, Ya-Ru, et al.
Publicado: (2022) -
Relationship among DDR gene mutations, TMB and PD-L1 in solid tumour genomes identified using clinically actionable biomarker assays
por: Wang, Danyi, et al.
Publicado: (2023) -
Tissue-Plasma TMB Comparison and Plasma TMB Monitoring in Patients With Metastatic Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors
por: Friedlaender, Alex, et al.
Publicado: (2020) -
Vertex Deletion into Bipartite Permutation Graphs
por: Bożyk, Łukasz, et al.
Publicado: (2022) -
Modeling the ribosome as a bipartite graph
por: Calvet, Laurie E.
Publicado: (2022)